About Ikris
Ikris pharma network is a Global Pharmaceutical Company founded with a deep commitment to improve global healthcare accessibility. We are more than a pharmaceutical services provider as we are a dedicated partner in ensuring that essential medicines reach those who need them most. We believe that timely access to the medications are very important irrespective of geographical or logistical challenges.
Transforming lives through Networking
Ikris Vision
Every patient is a unique story, a distinct journey towards health and wellness. We take pride in being a part of these journeys, providing the right medication at the right time. By providing medicines, we help patients reclaim their health, regain their strength, and resume their dreams. Our role transcends beyond merely dispensing medicines, its about instilling hope, fostering resilience, and making a real difference.
Ikris Mission
Our Mission is to provide patients, healthcare personnel within a country an independent global network, future products and services to satisfy unmet medical needs where current treatment is either unavailable or exhausted all other options
Our Set Of Values
1.
Creating Valuable
Partnerships
We believe that by forging strong partnerships, we can foster a culture of collaboration, accelerate the pace of healthcare innovation, and address healthcare disparities.
2.
Creating A Meaningful
Impact
Through relentless innovation, we strive to address unmet medical needs, enhance treatment efficacy, improve patient experiences, and ultimately create a meaningful impact.
3.
Pursuit
For Excellence
We work relentlessly and have an unwavering determination towards pushing the boundaries and Strive for Excellence in whatever we do.
4.
Embracing Diversity
And Inclusion
We aim to foster an inclusive environment where everyone feels welcome, respected, and able to contribute their unique perspective towards the journey.
Ikris Timeline
Our story through time
2014 - 2023
Ikris was Founded
2014
August
2014
August
Ikris was Founded
Ikris was Founded by Mr. Parveen Sikri after working in the Pharmaceutical industry for almost three Decades. He has worked with various companies which includes multinational and top Indian pharmaceutical companies. Mr Sikri thought of creating a life changing impact in the Healthcare Industry and this laid the foundation of Ikris Pharma Network.
Transforming Lives
2015
2015
Transforming Lives
Ikris has a strong focus towards Managed Access Program with the hardcore Vision of Transforming Lives through Networking. Every patient has a unique story, a distinct journey towards health and wellness. Ikris takes pride in being a part of these journeys, providing the right medication at the right time.
Proactive Diversification
2016
2016
Proactive Diversification
The company expands its Global footprint by setting up a new entity in Belgium – Ikris Pharma International, Belgium. The company is proud to receive the GDP Certificate from the Belgian Federal Agency for Medicines and Health Products with a certified pharmaceutical warehouse.
Quality Generic, Affordable Cure
2017
2017
Quality Generic, Affordable Cure
Ikris created a robust presence in International healthcare Exports. This expanded treatment repertoire providing new hope and potentially better outcomes for patients who exhausted other options.
Uniting Against Rarity
2018 – 2019
2018 – 2019
Uniting Against Rarity
Ikris served multiple patients with Rare diseases and also helped overcome challenges on the communities affected by rare diseases. Ikris continues to create a positive impact in this journey for the individuals with rare disease through its dedicated consistent efforts.
Beacon of Hope
2020
2020
Beacon of Hope
Ikris actively contributed to frontline efforts by ensuring access to medications crucial to fight against COVID. The company provided valuable assistance to several countries & been a trusted supplier of medications and medical services in crucial times.
Dynamic Expansion
2021
2021
Dynamic Expansion
Ikris Pharma Network also entered in strategic advancement of providing innovative solutions for sourcing of innovator samples (single batch/multiple batches of specific quantities) for clinical trials as well as bioequivalence studies. Ikris continues to expand with better presence in International markets and continues its growth in business i.e NPM and Rare disease segment.
Surpassing Milestones 2022 onwards
2022
2022
Surpassing Milestones 2022 onwards
Ikris is striving for Growth and has become now the biggest Named Patient Import Medicine Supplier. Ikris has partnered with new companies in the Oncology and Rare Disease segment such as Recordati Rare diseases, PTC Therapeutics, BioMarin, Sarepta Therapeutics, Servier Pharmaceuticals and Alexion to provide assistance to the patients and bring a meaningful impact in their lives.
Meet Our Team
Founder & CEO
Market Access Manager - Rare Diseases
Global Account Manager
.png)
Global Access Manager
Logistic Coordinator
Responsible Pharmacist
